← Leaderboards
Paul L Prather
University Of Arkansas Med Scis Ltl Rock
$5,475,459
Attributed
$5,475,459
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $739K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,475,459 · 6
By mechanism
R01$3,630,175 · 2
T32$1,157,490 · 2
R21$398,182 · 1
R29$289,612 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Arkansas Med Scis Ltl Rock
Same institution · by research overlap
- Richard R Drake$9,503,019
- Josep Dalmau$6,567,852
Others in their field
Top investigators on “Cannabinoids”
- Alexandros Makriyannis · University Of Connecticut Storrs$39,379,878
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$31,535,958
- Deepak Cyril D'souza · Va Connecticut Healthcare System$18,310,025
- Daniele Piomelli · University Of California Irvine$17,726,721
- Kenneth P. Mackie · Queen'S Medical Center$16,568,516
- Jenny L. Wiley · Virginia Commonwealth University$14,895,613
Research focus
CannabinoidsPharmacology And ToxicologyAgonistPharmaceutical PreparationsIn VivoDrug KineticsSymptomsLifeIn VitroComplex MixturesAcuteAgitationCnr1 GeneCnr2 GeneCytochrome P450Chinese Hamster Ovary CellAffinityCannabimimeticsChronicBindingAcute ToxicityCapsuleBiologicalAuditory Hallucination
Grant awards (27)
Training in Systems Pharmacology and Toxicology (T-SPaT)$175,012
T32 · FY2025 · GM · contact PI
Training in Systems Pharmacology and Toxicology (T-SPaT)$181,576
T32 · FY2024 · GM · contact PI
Training in Systems Pharmacology and Toxicology (T-SPaT)$174,046
T32 · FY2023 · GM · contact PI
Systems Pharmacology and Toxicology Training Program$168,193
T32 · FY2022 · GM · contact PI
Systems Pharmacology and Toxicology Training Program$155,100
T32 · FY2021 · GM · contact PI
Synthetic Cannabinoid Toxicity: Role of Biotransformation$555,072
R01 · FY2020 · DA · contact PI
Systems Pharmacology and Toxicology Training Program$152,870
T32 · FY2020 · GM · contact PI
Synthetic Cannabinoid Toxicity: Role of Biotransformation$21,743
R01 · FY2020 · DA · contact PI
Synthetic Cannabinoid Toxicity: Role of Biotransformation$544,846
R01 · FY2019 · DA · contact PI
Systems Pharmacology and Toxicology Training Program$150,693
T32 · FY2019 · GM · contact PI
Synthetic Cannabinoid Toxicity: Role of Biotransformation$43,485
R01 · FY2019 · DA · contact PI
Synthetic Cannabinoid Toxicity: Role of Biotransformation$539,732
R01 · FY2018 · DA · contact PI
Synthetic Cannabinoid Toxicity: Role of Biotransformation$43,485
R01 · FY2018 · DA · contact PI
Synthetic Cannabinoid Toxicity: Role of Biotransformation$539,701
R01 · FY2017 · DA · contact PI
Synthetic Cannabinoid Toxicity: Role of Biotransformation$43,485
R01 · FY2017 · DA · contact PI
Synthetic Cannabinoid Toxicity: Role of Biotransformation$549,674
R01 · FY2016 · DA · contact PI
Selective CB2 Cannabinoid Agonists as Candidate Therapeutics for ALS$156,334
R21 · FY2009 · NS · contact PI
Selective CB2 Cannabinoid Agonists as Candidate Therapeutics for ALS$43,123
R21 · FY2009 · NS · contact PI
Selective CB2 Cannabinoid Agonists as Candidate Therapeutics for ALS$10,672
R21 · FY2009 · NS · contact PI
Selective CB2 Cannabinoid Agonists as Candidate Therapeutics for ALS$188,053
R21 · FY2008 · NS · contact PI
CANNABINOID AGONIST REGULATION OF SIGNAL TRANSDUCTION$180,877
R01 · FY2004 · DA
CANNABINOID AGONIST REGULATION OF SIGNAL TRANSDUCTION$180,877
R01 · FY2003 · DA
CANNABINOID AGONIST REGULATION OF SIGNAL TRANSDUCTION$180,877
R01 · FY2002 · DA
OPIOID CONTROL MECHANISMS OF SIGNAL TRANSDUCTION$98,100
R29 · FY2002 · DA
CANNABINOID AGONIST REGULATION OF SIGNAL TRANSDUCTION$206,321
R01 · FY2001 · DA
OPIOID CONTROL MECHANISMS OF SIGNAL TRANSDUCTION$96,507
R29 · FY2001 · DA
OPIOID CONTROL MECHANISMS OF SIGNAL TRANSDUCTION$95,005
R29 · FY2000 · DA